Algernon Pharmaceuticals Inc.
AGN
CNSX
05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 0.31% | -74.99% | -42.17% | -1.12% | 695.02% |
Total Receivables | -19.26% | 40.63% | -17.24% | 73.13% | -70.74% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 274.41% | -34.70% | -58.62% | 88.00% | 327.35% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 65.37% | -66.17% | -44.49% | 8.74% | 454.52% |
|
|||||
Total Current Assets | 65.37% | -66.17% | -44.49% | 8.74% | 454.52% |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 38.10% | -2.89% | -2.97% | 1.07% | -16.86% |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 5.03% | -2.93% | -3.76% | 0.95% | -0.47% |
Total Assets | 51.59% | -10.26% | -10.75% | 2.43% | -2.05% |
|
|||||
Total Accounts Payable | 15.31% | -0.75% | 1.07% | 0.75% | -44.92% |
Total Accrued Expenses | 56.24% | 185.93% | 17.06% | -86.55% | -49.56% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 53.69% | 2.05% | 1.27% | -7.04% | -45.37% |
|
|||||
Total Current Liabilities | 53.69% | 2.05% | 1.27% | -7.04% | -45.37% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 67.85% | 2.05% | 1.27% | -7.04% | -45.37% |
|
|||||
Common Stock & APIC | 7.08% | -2.92% | -3.68% | 2.55% | -0.42% |
Retained Earnings | -6.83% | 6.67% | 2.60% | -2.17% | 5.03% |
Treasury Stock & Other | 20.47% | -48.76% | -4.76% | 4.49% | 1.06% |
Total Common Equity | 29.06% | -23.12% | -20.60% | 11.74% | 346.34% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 29.06% | -23.12% | -20.60% | 11.74% | 346.34% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 29.06% | -23.12% | -20.60% | 11.74% | 346.34% |
|